A multi-sectoral approach to antimicrobial resistance containment: Insights from One Health

Abstract

Antimicrobial resistance (AMR) has become a serious threat to global public health. By 2050, AMR is estimated to cause 1.91 million deaths annually, with related mortality reaching 8.22 million. The challenges posed by AMR extend beyond the healthcare system to include animal health and environmental factors such as livestock farming, urbanization, and climate change. The “One Health” approach, an interdisciplinary and cross-regional collaborative strategy, integrates the management of human, animal, and environmental health. It is considered a crucial framework for addressing complex public health challenges and providing both scientific and preventive strategies to combat AMR. From October 12 to 13, 2024, the Second One Health Conference of Antimicrobial Resistance Containment was successfully held in Hangzhou, Zhejiang Province, China, under the theme “Hand in Hand with One Health to Contain AMR”. The conference brought together experts from various fields to engage in in-depth discussions on AMR control, reaching a consensus to take action towards advancing the global health community. This conference strengthened multi-sectoral collaboration, promoted cross-departmental and cross-national cooperation, enhanced public awareness of AMR, explored control mechanisms, and provided both theoretical and practical guidance for mitigating AMR. It also called for increased investment and research and development efforts on AMR containment.

Keywords

One Health / Infectious diseases / Antimicrobial resistance

Conflict of interest statement

The authors declare that there is no conflict of interest.

Funding

This study received no extramural funding.

Data availability statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Authors’ contributions

Cheng Y, Wang XT, Ma YY, Chen T, Xiong LY, Chen P, Lu P, Zhang EJ wrote the original manuscrpit. Xiao YH reviewed the manuscript and contributed to projectadministration and conceptualization.

References

[1] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022; 399(10325): 629-655.

[2] Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A 2018; 115(15), E3463-E3470.

[3] O’neill JIM. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. [Online] Available from: https://wellcomecollection.org/works/rdpck35v. [Accessed on 28 October 2024].

[4] O’Neill JIM. Tackling drug-resistant infections globally: Final report and recommendations. [Online] Available from: https://amr-review.org/Publications.html. [Accessed 28 October 2024].

[5] Jonas OB, Irwin A, Berthe FCJ, LeGall FG, Patricio V. Drug-resistant infections: A threat to our economic future. [Online] Available from: https://www.worldbank.org/en/topic/health/publication/drug-resistant-infections-a-threat-to-our-economic-future. [Accessed 28 October 2024].

[6] Ventola CL. The antibiotic resistance crisis: part 1: Causes and threats. Pharm Ther 2015; 40(4): 277.

[7] Anderson M, Clift C, Schulze K, Sagan A, Nahrgang S, Ouakrim DA, et al. Averting the AMR crisis: What are the avenues for policy action for countries in Europe? [Online] Available from: https://pubmed.ncbi.nlm.nih.gov/31287637/. [Accessed 28 October 2024].

[8] Djordjevic SP, Jarocki VM, Seemann T, Cummins ML, Watt AE, Drigo B, et al. Genomic surveillance for antimicrobial resistance: A One Health perspective. Nat Rev Genet 2024; 25(2): 142-157.

[9] Hong SH, Bunge J, Jeon SO, Epstein SS. Predicting microbial species richness. Proc Natl Acad Sci U S A 2006; 103(1): 117-122.

[10] World Health Organization. One Health. [Online] Available from: https://www.who.int/news-room/fact-sheets/detail/one-health. [Accessed 28 October 2024].

[11] Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: A global perspective. Clin Microbiol Infect 2012; 18(7): 646-655.

[12] Habib I, Elbediwi M, Mohteshamuddin K, Mohamed M, Lakshmi GB, Abdalla A, et al. Genomic profiling of extended-spectrum β-lactamase-producing Escherichia coli from pets in the United Arab Emirates: Unveiling colistin resistance mediated by mcr-1.1 and its probable transmission from chicken meat-A One Health perspective. J Infect Public Health 2023; 16(Suppl 1): 163-171.

[13] Said LB, Jouini A, Klibi N, Dziri R, Alonso CA, Boudabous A, et al. Detection of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in vegetables, soil, and water of the farm environment in Tunisia. Int J Food Microbiol 2015; 203: 86-92.

[14] Song J, Oh SS, Kim J, Shin J. (2020). Extended-spectrum β-lactamase-producing Escherichia coli isolated from raw vegetables in South Korea. Sci Rep 2020; 10(1): 19721.

[15] Trueba G, Montero L, Irazabal J, Cardenas P, Graham JP. Extended-spectrum beta-lactamase producing Escherichia coli isolated from irrigation waters and produce in Ecuador. Front Microbiol 2021; 12: 709418.

[16] Gekenidis MT, Rigotti S, Hummerjohann J, Walsh F, Drissner D. Long-term persistence of bla(CTX-M-15) in soil and lettuce after introducing extended-spectrum β-lactamase (ESBL)-producing Escherichia coli via manure or water. Microorganisms 2020; 8(11): 1671.

[17] Ludden C, Moradigaravand D, Jamrozy D, Gouliouris T, Blane B, Naydenova P. A One Health study of the genetic relatedness of Klebsiella pneumoniae and their mobile elements in the east of England. Clin Infect Dis 2020; 70(2): 219-226.

[18] de Barros M, da Silva Lopes I, Moreira AJ, Almeida RDSO, da Costa MM, Mota RA. Multidrug efflux system-mediated resistance in Staphylococcus aureus under a One Health approach. World J Microbiol Biotechnol 2023; 40(1): 9.

[19] Lim SC, Knight DR, Riley TV. Clostridium difficile and One Health. Clin Microbiol Infect 2020; 26(7): 857-863.

[20] Sixty-eighth World Health Assembly. Global action plan on antimicrobial resistance WHA68.7. [Online] Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_R7-en.pdf. [Accessed on 28 October 2024].

[21] National Health Commission. Notice on the issuance of the National Action Plan for the containment of microbial resistance (2022-2025). [Online] Available from: https://www.cn-healthcare.com/articlewm/20221031/content-1458660.html. [Accessed on 28 October 2024].

[22] Gibbs EPJ. The evolution of One Health: A decade of progress and challenges for the future. Vet Rec 2014; 174(4): 85-91.

[23] World Health Organization. Global Action Plan on antimicrobial resistance. [Online] Available from https://www.who.int/publications/i/item/9789241509763. [Accessed on 28 October 2024].

[24] Food and Agriculture Organization of the United Nations. The FAO Action Plan on antimicrobial resistance 2016-2020. [Online] Available from: https://www.fao.org/policy-support/tools-and-publications/resources-details/en/c/459933/. [Accessed on 28 October 2024].

[25] World Organization for Animal Health. The OIE strategy on antimicrobial resistance and the prudent use of antimicrobials. [Online] Available from: https://www.woah.org/fileadmin/Home/eng/Media_Center/docs/pdf/PortailAMR/EN_OIE-AMRstrategy.pdf. [Accessed on 28 October 2024].

[26] United Nations. UN high-level meeting on antimicrobial resistance. [Online] Available from: https://www.un.org/en/civil-society/high-level-meeting-antimicrobial-resistance. [Accessed on 28 October 2024].

[27] European Commission. A European One Health Action Plan against antimicrobial resistance (AMR). [Online] Available from: https://eur-lex.europa.eu/EN/legal-content/summary/a-european-one-health-action-plan-against-antimicrobial-resistance.html. [Accessed on 28 October 2024].

[28] Veterinary Medicines Directorate. UK One Health report: Joint report on antibiotic use and antibiotic resistance, 2013-2017. [Online] Available from: https://assets.publishing.service.gov.uk/media/656488f11524e60011a100f8/_2681096-v1-Third_UK_One_Health_Report.PDF. [Accessed on 28 October 2024].

[29] Centers for Disease Control and Prevention. U.S. action & events to combat antibiotic resistance. [Online] Available from: https://www.cdc.gov/antimicrobial-resistance/programs/AR-actions-events.html. [Accessed on 28 October 2024].

[30] World Health Organization. Tracking AMR country self-assessment survey-TrACSS (7.0) 2023. [Online] Available from: https://www.who.int/publications/m/item/tracking-amr-country-self-assessment-survey-tracss-%287.0%29-2023. [Accessed on 28 October 2024].

[31] Nie EQ, Xia Y, Wang T, Lu JH. One Health-A new approach to control emerging infectious diseases. J Microb Infect 2016; 11(1): 3-7.

[32] Gao GF, Chen JS, Zhao GP, Xu JG. Lu JH. The 697th Xiangshan science conference consensus report on One Health and human health. One Health Bull 2021; 1(1): 3-9.

[33] Ministry of Agriculture and Rural Affairs of the PRC. Measures for the administration of prescription and non-prescription veterinary drugs. [Online] Available from: https://www.gov.cn/zhengce/2022-10/12/content_5721384.htm. [Accessed on 28 October 2024].

[34] China Veterinary Medical Association. National food safety standard maximum residue limit of veterinary drugs in food. [Online] Available from: http://www.cvda.org.cn/a/zhengjingban/zhengcefagui/shouyaoanquanshiyonggu/2021/0916/23445.html. [Accessed on 28 October 2024].

[35] Collaborators GAR. Global burden of bacterial antimicrobial resistance 1990-2021: A systematic analysis with forecasts to 2050. Lancet 2024; 404(10459): 1199-1226.